Announcements Trials
Browse Landscape

Phase

Phase NA 21Phase 4 10Phase 1 8Phase 3 6Phase 2/3 5Phase 2 4Phase 1/2 3Phase EARLY_PHASE1 1

Status

Completed 4Terminated 3Recruiting 3Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Breast Neoplasms 2Leiomyoma 1Inflammatory Bowel Diseases 1Diverticulitis 1Colonic Neoplasms 1Agnosia 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × Lidocaine × Clear all
NCT01204242 2022-03-24

IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery:

University of Virginia

Phase 2 Completed
78 enrolled
Breast

Breast Neoplasms

NCT02839668 2019-10-29

TIVA/TCI-BC

Iuliu Hatieganu University of Medicine and Pharmacy

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms

NCT02270255 2019-08-14

Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Completed
44 enrolled 8 charts

Agnosia, Leiomyoma

NCT01155440 2011-11-28

Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Completed
60 enrolled
Gastrointestinal

Colonic Neoplasms, Diverticulitis, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡